These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5934901)

  • 21. Therapeutic potential of biological response modifiers against transplantable mouse tumors of spontaneous origin. I. Characterization of biological properties of tumor lines and preliminary data on response to cytostatic drugs and biomodulators.
    Fiszer-Maliszewska L; Mordarski M; Madej JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):1-9. PubMed ID: 8239902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicine. Building better mouse models for studying cancer.
    Marx J
    Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
    [No Abstract]   [Full Text] [Related]  

  • 23. [Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives].
    Pan XD; Liu HY; Sun PY; Zhu CG; Yang J; Yuan KH; Han R
    Yao Xue Xue Bao; 2004 Aug; 39(8):591-7. PubMed ID: 15563058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified screening system to select new cytostatic drugs.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326
    [No Abstract]   [Full Text] [Related]  

  • 25. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy.
    Emerich DF; Snodgrass P; Dean RL; Lafreniere D; Agostino M; Wiens T; Xiong H; Hasler B; Marsh J; Pink M; Kim BS; Bartus RT
    J Pharmacol Exp Ther; 2001 Feb; 296(2):623-31. PubMed ID: 11160651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of xenografts for the evaluation of tumor chemotherapy. Application to adjuvant chemotherapy].
    Duplan JF
    Bull Cancer; 1984; 71(4):292-6. PubMed ID: 6498344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minicells mitigate tumor growth.
    Dorans K
    Lab Anim (NY); 2009 Aug; 38(8):250. PubMed ID: 19626008
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
    Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
    Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation of the anticarcinogenic properties of mercenene: part II.
    Fishtein MB; Sheridan JF
    J Am Osteopath Assoc; 1970 Jun; 69(10):1042-5. PubMed ID: 5201429
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.
    Castillo R; Díaz JW; Veloso A; Gavilondo J
    Neoplasma; 1982; 29(1):73-9. PubMed ID: 7070557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some biological characteristics of transplantable lines of mouse adenocarcinomas of the colon.
    Cowen DM; Double JA; Cowen PN
    J Natl Cancer Inst; 1980 Mar; 64(3):675-81. PubMed ID: 6928251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological aspects of the subrenal capsule assay of importance in the screening of cytostatic agents.
    Edelstein MB; Smink T; van Putten LM
    Behring Inst Mitt; 1984 May; (74):285-90. PubMed ID: 6477357
    [No Abstract]   [Full Text] [Related]  

  • 36. A new transplantable mouse tumour and its ultrastructural characteristics.
    Rejthar A; Karásek J; Chlumecký J
    Neoplasma; 1969; 16(5):501-11. PubMed ID: 5364145
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing growth and response to therapy in murine tumor models.
    Reynolds CP; Sun BC; DeClerck YA; Moats RA
    Methods Mol Med; 2005; 111():335-50. PubMed ID: 15911989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
    Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM
    Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor vascular targeting with tumor necrosis factor alpha and chemotherapeutic drugs.
    Corti A; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():104-12. PubMed ID: 15650236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory response of tumor-activated hepatic sinusoidal endothelium as a target for the screening of metastasis chemopreventive drugs.
    Mendoza L; Vidal-Vanaclocha F
    Methods Mol Med; 2003; 85():107-15. PubMed ID: 12710201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.